Autopsy report · NCT04533074
Microbiological Evaluation of Single Versus Multiple Visits Regeneration Using MALDI-TOF Mass Spectrometry
Cause of deathStaffing, sites or logistics
“due to the COVID-19 pandemic”
Life of this trial
- Registered 2 years after it had already started.
- Ran for about 2 years 7 months before it stopped.
- 16 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Nourhan M.Aly
- Sponsor type
- University, hospital or other
- Conditions
- Pulp Necroses; Tooth, Nonvital
- Interventions
- Single-visit regeneration protocol; Multiple-visits regeneration protocol
- Participants
- 16
- Sites
- 1
- Countries
- Egypt
Trials that died the same way
- Three Dimensional Facial Growth Analysis
“Due to Covid-19 pandemic” - Effect of Global Postural Re-education in Idiopathic Scoliosis
“Because of the COVID-19 pandemic” - OPEP Devices in Acute Inpatient Treatment of Pneumonia
“due to COVID-19” - Virtual Reality for the Treatment of Chronic Low Back Pain
“Due to the impact of COVID-19” - Effects of Stoss Therapy of Vitamin D3 on Peri-operative Outcomes in Patients Receiving General Surgery
“Because of impact from COVID-19 pandemic”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.